XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Prior to the completion of the Spin-Off, the Company had no common shares issued and outstanding. On April 1, 2024, there were 172,709,505 shares of Solventum common stock issued and outstanding as part of the Distribution. For the nine months ended September 30, 2024, these shares are treated as issued and outstanding for purposes of calculating historical earnings per share.
Subsequent to Spin-Off, the dilutive effect of outstanding stock options, restricted stock units (“RSUs”) and performance share units (“PSUs”) is reflected in the calculation of earnings per share using the treasury stock method. Diluted earnings per share excludes certain shares issuable under stock-based compensation plans because the effect would have been antidilutive.
The computations for basic and diluted earnings per share are as follows:
Three months ended September 30,Nine months ended September 30,
(Amounts in millions, except per share amounts)2025202420252024
Numerator:
Net income$1,266 $122 $1,493 $448 
Denominator:
Weighted average common shares outstanding – basic
174.3 173.4 174.0 173.1 
Dilution associated with stock-based compensation plans1.1 0.5 1.1 0.3 
Weighted average common shares outstanding – diluted175.4173.9175.1173.4
Basic earnings per share$7.26 $0.70 $8.58 $2.59 
Diluted earnings per share $7.22 $0.70 $8.53 $2.58 
Antidilutive shares4.3 5.0 4.1 5.0